Skip to main content
. 2021 Mar 31;99(7):464–470. doi: 10.1159/000515441

Table 1.

Demographic and clinical data of 36 HNSCC patients

Cancer origin Oral cavity Larynx 26 (72.2)
10 (27.8)

Gender Females 14 (38.9)
Male 22 (61.1)

Age at diagnosis, years 58.8±13.1

Comorbidities Comorbidities presence 24 (66.7)
No comorbidities 12 (33.3)

Smoking habit Smoking 14 (40)
No smoking 21 (60)

Disease stage Stage 1 3 (8.3)
Stage 2 8 (22.2)
Stage 3 3 (8.3)
Stage 4 22 (61.1)

OS 82.9% (95% CI 67–94) 76% (95% CI 56–91.3)
DFS 3-year survival 82.2% (95% CI 66–94) 5-year survival 82.2% (95% CI 66–94)
PFS 59.4% (95% CI 40–77) 59.4% (95% CI 40–77)

Values are presented as n (%) or as indicated.